Nine previously unknown mutations in the SBF2 gene were found to cause an extremely rare…
Ana Pena, PhD
Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Regenacy Pharmaceuticals is partnering with the Charcot-Marie-Tooth Association (CMTA) to help…
Acceleron’s therapy candidate ACE-083 was seen to improve total and contractile muscle volume in patients…
Mutations in DHTKD1, a recently discovered cause of a Charcot-Marie-Tooth (CMT) type 2 subtype, can lead to the disease through…
A new study has evaluated and identified the best tests to use as outcome measures, which help doctors…
Charcot-Marie-Tooth (CMT) disease type 4CÂ is the most common recessive form of the…